Fig. 7.
Fig. 7. Inhibition of chemotaxis by truncated IP-10(3-77) and I-TAC(3-73). / The antagonistic activity of CD26/DPP IV–truncated IP-10 and I-TAC was tested on CXCR3-transfected cells in the Boyden microchamber. Intact agonistic IP-10 or I-TAC (at 10 or 30 nM) was added with or without 30 nM truncated chemokine [IP-10(3-77) or I-TAC(3-73)] to the bottom well of the chemotaxis chamber. Results represent the mean (± SEM) percent inhibition of the chemotactic index (CI) toward intact chemokine alone from 4 to 5 independent experiments. The Studentt test was used for statistical analysis comparing the CI with and without addition of truncated chemokine (** = P < .05; *** = P < .01).

Inhibition of chemotaxis by truncated IP-10(3-77) and I-TAC(3-73).

The antagonistic activity of CD26/DPP IV–truncated IP-10 and I-TAC was tested on CXCR3-transfected cells in the Boyden microchamber. Intact agonistic IP-10 or I-TAC (at 10 or 30 nM) was added with or without 30 nM truncated chemokine [IP-10(3-77) or I-TAC(3-73)] to the bottom well of the chemotaxis chamber. Results represent the mean (± SEM) percent inhibition of the chemotactic index (CI) toward intact chemokine alone from 4 to 5 independent experiments. The Studentt test was used for statistical analysis comparing the CI with and without addition of truncated chemokine (** = P < .05; *** = P < .01).

Close Modal

or Create an Account

Close Modal
Close Modal